GWSG
ITCI

GPS Wealth Strategies Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

GPS Wealth Strategies Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$132K – 1677
2025
Q1 		$132K Hold
1,000
– – 0.02% 394
2024
Q4 		$83.5K Hold
1,000
– – 0.01% 473
2024
Q3 		$73.2K Hold
1,000
– – 0.01% 512
2024
Q2 		$68.5K Hold
1,000
– – 0.01% 473
2024
Q1 		$69.2K Hold
1,000
– – 0.01% 447
2023
Q4 		$71.6K Hold
1,000
– – 0.01% 417
2023
Q3 		$52.1K Hold
1,000
– – 0.01% 477
2023
Q2 		$63.3K Hold
1,000
– – 0.01% 447
2023
Q1 		$54.1K Buy
+1,000
New +$48.3K 0.01% 465
2022
Q4 		– Sell
-1,000
Closed -$47K – 1134
2022
Q3 		$47K Hold
1,000
– – 0.01% 445
2022
Q2 		$57K Hold
1,000
– – 0.01% 423
2022
Q1 		$61K Buy
+1,000
New +$51.9K 0.01% 390

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GPS Wealth Strategies Group's ITCI Position: Q2 2025 in Review

GPS Wealth Strategies Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,000 shares — an estimated $132K sold.

GPS Wealth Strategies Group first reported a position in ITCI in Q1 2022 and held it in 12 quarters. The position peaked at $132K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • GPS Wealth Strategies Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 1,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $132K.
  • GPS Wealth Strategies Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2022 and held it in 12 quarters.
  • GPS Wealth Strategies Group's Intra-Cellular Therapies Inc. position peaked at $132K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2025, filed 5 Aug 2025.